Since 1980, IGEA has developed innovative and effective therapies.
The company's engine is the Research and Development, a staff of experts developing and studying devices for medicine, real new therapies to promote the healing of fractures and the protection of joints and the treatment of solid tumors.
A research work and a constant commitment has brought about the publication of 600 scientific papers.
Each IGEA therapy is designed, developed and implemented following a path similar to that of drug development, to offer patients efficacy and safety.
The IGEA Medical Division then follows the clinical development of the IGEA Therapies up to commercialisation whereafter.
The IGEA Quality Control Office supervises the work of qualified technicians, who assembles and tests the medical devices and provides technical support and assistance.
Throughout the national and international territories the IGEA Sales and Marketing Network updates the medical profession on the clinical indications of the various IGEA therapies and on the most appropriate use for optimal patient treatment.
The IGEA Customer Service Team are available to answers any questions and provides assistance to the treating medical team.